Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × Irinotecan × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 8 Pancreatic Neoplasms 6 Neoplasm Metastasis 6 Sarcoma, Ewing 5 Rhabdomyosarcoma 4 Colonic Neoplasms 4 Sarcoma 3 Rectal Neoplasms 3 Neuroblastoma 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2 Recurrence 2 Pathologic Complete Response 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neoplasms 2 Medulloblastoma 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Ependymoma 2 Endometrial Neoplasms 2 Colorectal Adenocarcinoma 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdoid Tumor 1

Interventions

Rituximab 19 Cyclophosphamide 19 Prednisone 13 Lenalidomide 11 Doxorubicin 11 Oxaliplatin 9 Gemcitabine 9 fludarabine 8 Specimen Handling 8 Vincristine 7 Magnetic Resonance Spectroscopy 7 polatuzumab vedotin 6 Etoposide 6 glofitamab 5 CT-P10 5 venetoclax 4 obinutuzumab 4 ibrutinib 4 fludarabine phosphate 4 axicabtagene ciloleucel 4 Biopsy 4 deltacortene 3 Prednisolone 3 Leukapheresis 3 Ifosfamide 3 prednylidene 2 pembrolizumab 2 acalabrutinib 2 Whole-Body Irradiation 2 Spinal Puncture 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡